Suboxone Film, Soluble
Product Images NDC 12496-1204

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Suboxone (NDC 12496-1204). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Indivior Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sub01 0035 01

Chemical structure of buprenorphine hydrochloride, showing its molecular framework with labeled atoms and bonds, including a cyclopropyl group and various ring structures.*

FDA Label Image

Sub01 0035 02

Chemical structure diagram of buprenorphine hydrochloride, showing its molecular framework including rings, hydroxyl groups, and an alkene side chain. The image includes the hydrochloride and dihydrate (2H2O) notation.*

FDA Label Image

Sub01 0035 03

Instructional illustrations showing hands opening a sachet containing Suboxone buccal/sublingual soluble film. The images demonstrate peeling back the sachet to access the film inside, intended for application in the mouth.*

FDA Label Image

Sub01 0035 04

Instructional illustrations showing opening steps for a Suboxone film packet. The left image depicts hands peeling open the top of a foil sachet, and the right image shows the sachet being cut open with scissors. Text on the sachet is partially visible but not legible.*

FDA Label Image

Sub01 0035 05

An instructional illustration showing the placement of a Suboxone film inside the mouth on the buccal or sublingual area, positioned against the inner cheek or under the tongue for dissolution.*

FDA Label Image

Sub01 0035 06

Illustration showing the proper placement of a Suboxone soluble film inside the mouth. The left image depicts a person pulling the cheek outward to place the film on the buccal mucosa, while the right image shows the film adhered inside the mouth, illustrating buccal or sublingual administration.*

FDA Label Image

Sub01 0035 07

Packaging label for Suboxone sublingual film, containing 2 mg buprenorphine and 0.5 mg naloxone per film. The label indicates it is for prescription use only and instructs not to cut, chew, or swallow the film. The product is a single sublingual film dosage form by Indivior Inc.*

FDA Label Image

Sub01 0035 08

Suboxone 2 mg/0.5 mg sublingual film carton by Indivior Inc. The packaging indicates 30 pouches each containing one sublingual film with buprenorphine and naloxone. The label includes usage instructions such as not to cut, chew, or swallow the film, and storage information to keep at controlled room temperature. It features barcodes and safety warnings for accidental ingestion in children.*

FDA Label Image

Sub01 0035 09

Label of Suboxone sublingual film with a strength of 4 mg/1 mg, containing buprenorphine and naloxone. The label includes instructions not to cut, chew, or swallow the film and safety warnings to keep it out of reach of children. It is manufactured by Indivior Inc. The label mentions the route of administration as sublingual and provides detailed usage instructions.*

FDA Label Image

Sub01 0035 10

Suboxone 4 mg/1 mg sublingual film packaging label displays the proprietary name Suboxone and generic names buprenorphine and naloxone. The label indicates 30 pouches, each containing one sublingual film, with dosing instructions for sublingual and buccal administration. It includes warnings about accidental ingestion by children and directions for pharmacist dispensing. The labeler is Indivior Inc.*

FDA Label Image

Sub01 0035 11

Suboxone 8 mg/2 mg sublingual film packaging label showing the product name, strengths of buprenorphine and naloxone, and directions indicating it is Rx only. The label advises not to cut, chew, or swallow the film and includes safety warnings to keep it out of reach of children. The labeler is Indivior Inc.*

FDA Label Image

Sub01 0035 12

Packaging label for Suboxone buprenorphine and naloxone sublingual film, strength 8 mg/2 mg. The label displays the product name, active ingredients, dosage form as sublingual film, and package quantity of 30 pouches. It includes instructions for use, storage conditions, pharmacist instructions, and cautionary statements. Labeler is Indivior Inc.*

FDA Label Image

Sub01 0035 13

Suboxone sublingual film 12 mg/3 mg with buprenorphine and naloxone, indicated for sublingual use. The label shows a single film strip with warnings to not cut, chew, or swallow the film and a caution about emergency care for accidental ingestion by children. Manufactured by Indivior Inc., the packaging includes instructions for sublingual and buccal administration and storage information.*

FDA Label Image

Sub01 0035 14

Suboxone 12 mg/3 mg sublingual film carton label showing formulation with buprenorphine and naloxone. The label indicates 30 pouches each containing 1 sublingual film. It is labeled for prescription use only and includes warnings to keep out of children's reach and not to cut or chew the film. Manufactured by Indivior Inc., the packaging includes usage instructions and pharmacist guidance to dispense the Medication Guide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.